ALLOB, created in 2011 (Belgium), from 6 sister brands and 2214 competing brands. The ALLOB brand is owned by Bone Therapeutics, a company listed in Bruxelles. The ISIN, the company's International Securities Identification Number, is BE0974280126. ALLOB is part of the Biotechnology activity sector.

ALLOB is a brand of Bone Therapeutics (BIOS) Share price

International deposit : 2011 Business sector Biotechnology

Share price and profitability of the share Bone Therapeutics (ALLOB)

Buy Bone Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 0.02

Portfolio valuation
Bone Therapeutics (ALLOB) over 5 years* EUR 0.00

Stock market history Bone Therapeutics (ALLOB)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Bone Therapeutics

See more brands of Bone Therapeutics

Rival brands
ALLOB

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS